Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F25%3A00081820" target="_blank" >RIV/65269705:_____/25:00081820 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/25:00141301
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S1473309924007497" target="_blank" >https://www.sciencedirect.com/science/article/pii/S1473309924007497</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/S1473-3099(24)00749-7" target="_blank" >10.1016/S1473-3099(24)00749-7</a>
Alternative languages
Result language
angličtina
Original language name
Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM
Original language description
Candida species are the predominant cause of fungal infections in patients treated in hospital, contributing substantially to morbidity and mortality. Candidaemia and other forms of invasive candidiasis primarily affect patients who are immunocompromised or critically ill. In contrast, mucocutaneous forms of candidiasis, such as oral thrush and vulvovaginal candidiasis, can occur in otherwise healthy individuals. Although mucocutaneous candidiasis is generally not life-threatening, it can cause considerable discomfort, recurrent infections, and complications, particularly in patients with underlying conditions such as diabetes or in those taking immunosuppressive therapies. The rise of difficult-to-treat Candida infections is driven by new host factors and antifungal resistance. Pathogens, such as Candida auris (Candidozyma auris) and fluconazole-resistant Candida parapsilosis, pose serious global health risks. Recent taxonomic revisions have reclassified several Candida spp, potentially causing confusion in clinical practice. Current management guidelines are limited in scope, with poor coverage of emerging pathogens and new treatment options. In this Review, we provide updated recommendations for managing Candida infections, with detailed evidence summaries available in the appendix.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30303 - Infectious Diseases
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Lancet Infectious Diseases
ISSN
1473-3099
e-ISSN
1474-4457
Volume of the periodical
25
Issue of the periodical within the volume
5
Country of publishing house
GB - UNITED KINGDOM
Number of pages
14
Pages from-to
"e280"-"e293"
UT code for WoS article
001484403300001
EID of the result in the Scopus database
2-s2.0-105001221701